- Job postings
New Stockholm office
OstomyCure has moved its Stockholm operations from Kista to the Karolinska Campus area in Solna in the heart of the bustling Stockholm life science scene.
We are happy to be the first tenant in the beautifully renovated offices at the all new “A Working Lab” by Akademiska Hus on Nanna Svartz väg 4-6. Here we have our own private office, well suited facilities for logistics and warehousing, ample of space for visitors and meetings, top-of-the-line video conferencing rooms, etc. All in a historical setting with beautiful surroundings and inspiring neighbours for creative networking. Come and see us!
Message from Ostomycure CEO, Graeme Smith.
Today the first patient was enrolled in the TIES03 study of the OstomyCure Transcuteous Implant Evacuation System (TIES®).
OstomyCure AS® has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.
Approval for multicenter study “TIES-C03” in major university hospitals in Leeds, UK & Umeå, Sweden.
Message from CEO Ostomycure Dr Benedict Broenniman M.D.
OstomyCure today announced the appointment of Cindy Wong, M.D. as Chief Medical Officer (CMO).
OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal.
OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System.
The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden.